Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?
"Prudent" vitamin supplement users should limit potency to 100% RDA -- ADA.
NON-VITAMIN SUPPLEMENTS "MAY BE MORE FRAUD THAN FACT," ADA opines in its new Complete Food & Nutrition Guide, authored by registered dietitian Roberta Larson Duyff. Many supplement products, the American Dietetic Association book says, including "herbal remedies, amino acids, enzymes, plant extracts, other botanicals, and concentrates...don't provide the benefits they claim. Others may have harmful side effects. Some may be more fraud than fact." The book was introduced at ADA's 79th annual meeting, held Oct. 21-24 in San Antonio, Tex.
More from Archive
• By
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
• By
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
• By
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
• By
A new pilot aims to take Brazil closer to ‘digital transformation.’
More from Pink Sheet
• By
The European Medicines Agency’s human medicines committee, the CHMP, has recommended 14 new medicines for pan-EU approval this month, including five orphan medicines.
• By
The European Medicines Agency says that Eli Lilly's Alzheimer's disease drug should be approved for use in the EU, now that it has re-examined the negative opinion it previously adopted.
• By
The European Medicines Agency recommended against pan-EU marketing authorization of Roche/Sarpeta’s gene therapy Elevidys for the treatment of Duchenne muscular dystrophy as the US reported another death in an Elevidys patient.